课题基金 / 基金详情

COMPLEMENT--PLASMA MEMBRANE FUNCTIONAL INTERACTIONS

COMPLEMENT--PLASMA MEMBRANE FUNCTIONAL INTERACTIONS
补体--质膜功能相互作用
批准号:
6330018
负责人:
ANNE NICHOLSON-WELLER
金额:
$34.97万
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-07-01 至 2002-11-30

项目摘要

项目成果

ANNE NICHOLSON-WELLER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Complement is a circulating system composed of many different proteins which is known for its ability to lyse animal cells and bacteria. This application seeks support for a series of investigations on the effects of complement on that do not lead to lysis of the target cell: the sublytic events. This proposal stems from our observation that when complement is activated at sublytical concentrations, influx of Na and L-glucose into the unlysed erthrocytes increases dramatically, albeit transiently, and yet the affected cells do not lyse or swell, as would be expected. We found that this non-lethal permeability increase is produced by the membrane attack complex, which is a macromolecular complex of the terminal complement components. Further we determined that C8, but not C9, is necessary to produce the sublytic change in permeability and that in response to the sublytic complement attack, there is activation of a Ca-dependent K permeability pathway. This promotes net K efflux and prevents the colloidosmotic swelling and lysis that occurs when the membrane damage is permanent and permits the survival of the affected cell. In PNH, a disease characterized by a dramatic increase in the sensitivity of erythrocytes to complement lysis, there is apparently a lack of sublytic changes for reasons not yet completely understood. Our specific aims include: 1) continue our studies on the complement regulatory proteins DAF and C8bp, particularly in relation to their role in the sublytic events; 2) characterize further the transient permeability changes and the volume regulatory transport mechanism through studies on ion fluxes during exposure to sublytic complement; and 3) determine the biological consequences of the sublytic events to the cells that survive a complement attack. We will perform studies in normal and PNH erthrocytes, as well as in cells carrying abnormal hemoglobin, such as SS, SC, or CC which are known to have volume regulatory pathways that we predict would decrease their sensitivity to complement lysis. We expect that our investigations will help better understanding complement mediated diseases, such as lupus erythematous and immune hemolytic anemia, and also provide important information on the physiological functions of the complement system and its regulatory proteins.
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1182/blood.v81.1.200.bloodjournal811200
发表时间: 1993
期刊: Blood
影响因子: 20.3
作者: [J. Halperin;A. Taratuska;M. Rynkiewicz;A. Nicholson‐Weller]
通讯作者: J. Halperin;A. Taratuska;M. Rynkiewicz;A. Nicholson‐Weller
DOI: 10.4049/jimmunol.148.1.124
发表时间: 1992-01
期刊: Journal of immunology
影响因子: 4.4
作者: [J. Laclette;Charles B. Shoemaker;D. Richter;L. Arcos;Nelly Panté;C. Cohen;D. Bing;A. Nicholson‐Weller]
通讯作者: J. Laclette;Charles B. Shoemaker;D. Richter;L. Arcos;Nelly Panté;C. Cohen;D. Bing;A. Nicholson‐Weller
Mechanisms by which the erythrocyte protects itself from complement damage.
红细胞保护自身免受补体损伤的机制。
DOI: --
发表时间: 1989
期刊: Progress in clinical and biological research
影响因子: --
作者: [Nicholson-Weller,A, Halperin,JA]
通讯作者: Halperin,JA
DOI: 10.1159/000463072
发表时间: 1989
期刊: Complement and inflammation
影响因子: --
作者: [Halperin,JA, Nicholson-Weller,A]
通讯作者: Nicholson-Weller,A
18
    CR1 (CD35) AS A CELLULAR RECEPTOR FOR CIQ
    CRI (CD35) As a Cellular Receptor for CIq
    CR1 (CD35) AS A CELLULAR RECEPTOR FOR CIQ
    CR1 (CD35) AS A CELLULAR RECEPTOR FOR CIQ
    海外基金